Do you have High Cholesterol?

Research studies are enrolling now!

Those who qualify may receive*:

  • Payment up to $500, which varies by study
  • Study-related care at no cost from local doctors
  • Study medication at no cost

Ready to get started? Click Here.

If you’ve been diagnosed with High Cholesterol, you may be concerned about your risks. Left untreated, high cholesterol can cause serious health problems, including heart attack, stroke, and liver disease.

Why does this occur? Cholesterol is a type of fat in your blood. It plays many important roles in your body, such as making hormones, helping digestion and ensuring proper brain function. But when you have too much cholesterol, it can build up and damage your arteries. When this happens, your blood doesn’t flow as easily, and you are at risk for heart disease and stroke. High cholesterol may also increase fat deposits in your liver, putting you at risk for nonalcoholic fatty liver disease (NAFLD). Lowering your cholesterol may reduce your risk of these serious conditions.

Right now, local research studies are evaluating a study medication that addresses high cholesterol and its dangerous effect in the body. You may be eligible to participate!

Take the next step to see if you qualify for local research studies for people with High Cholesterol. But don’t delay — space is limited!

* In a research study, the participants may receive investigational study product or may receive an inactive substance, or placebo, depending on the study design. Participants receive study-related care from a doctor/research team for the duration of the study. Reasonable payments will be made for participation and the length of the study may vary.

Ready to get started?

Click Here.

How does it work?


Tell us a little bit about yourself


Answer some questions about your health


We will connect you to available studies in your area

Just takes a few minutes


AcurianHealth helps connect people with research studies that offer treatment under development. Since 1998, AcurianHealth has referred 1 million study candidates to 800 studies in 70 countries.